Somatropin biosimilar - BiosidusAlternative Names: Growmax™; HHT; Somatrop; Somatropin Biosidus Injection
Latest Information Update: 20 Sep 2013
At a glance
- Originator Biosidus S.A.
- Class Growth hormones; Hormonal replacements
- Mechanism of Action Somatotropin receptor agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Marketed Somatotropin deficiency
Most Recent Events
- 15 Mar 2016 Biomarkers information updated
- 14 May 2012 Launched for Somatotropin deficiency in Brazil (SC)
- 10 Aug 2011 Launched for Somatotropin deficiency in Argentina (SC)